{"id":"W3096720517","doi":"10.1080/21645515.2020.1829899","title":"A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults","year":2020,"lang":"en","type":"article","venue":"Human Vaccines & Immunotherapeutics","topic":"Respiratory viral infections research","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"ca_institutions":"Micropharma (Canada)","funders":"Merck Sharp and Dohme","keywords":"Immunogenicity; Medicine; Tolerability; Placebo; Immunology; Adverse effect; Neutralizing antibody; Antibody titer; Randomized controlled trial; Immune system; Placebo-controlled study; Antibody; Titer; Internal medicine; Double blind; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003141038,0.0003988033,0.001491889,0.0003312886,0.0003184882,0.00006984401,0.000241869,0.0001067028,0.000184607],"category_scores_gemma":[0.0003617001,0.0002563215,0.0001576854,0.0005930477,0.00008588913,0.0001768787,0.0001370173,0.0005229726,0.000004703937],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009465903,"about_ca_system_score_gemma":0.0001752946,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005415647,"about_ca_topic_score_gemma":0.0002919597,"domain_scores_codex":[0.9954091,0.001706416,0.001366783,0.0005752334,0.0005316149,0.0004108708],"domain_scores_gemma":[0.9980676,0.0003548597,0.0002548133,0.0007262306,0.0003849338,0.0002115205],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8955341,0.003338458,0.002748044,0.0002058028,0.0004240596,0.00001187436,0.005152245,0.00004489308,0.08459947,0.00001964891,0.000004623946,0.007916813],"study_design_scores_gemma":[0.9378494,0.01579816,0.02939435,0.0002597522,0.0004097222,0.00001121234,0.0009098171,0.01011994,0.004780666,0.00001829795,0.0001588399,0.000289862],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9773035,0.002941936,0.0001452548,0.002044002,0.00003282057,0.01744033,0.000008625692,0.00005752929,0.00002602007],"genre_scores_gemma":[0.9970318,0.0001097016,0.0001035609,0.001869477,0.00008044956,0.0006799593,0.00001094012,0.00006736277,0.00004673248],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0798188,"threshold_uncertainty_score":0.9999889,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03899864370948746,"score_gpt":0.3797620391137306,"score_spread":0.3407633954042432,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}